Where do innovative drugs come from?

Drug Discovery Today

Volumn 16, Issue 21-22, 2011, Pages 907-909

  Higgs, Gerry ^a  

^a PharmaconEurope   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CIMETIDINE; FLUOXETINE; INFLIXIMAB; MEVINOLIN; RANITIDINE; ZIMELDINE;

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; HEALTH SERVICE; LICENSING; REVIEW;

EID: 80255122640     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.08.012     Document Type: Editorial

References (6)

1. L.J.S. Knutsen Drug discovery management, small is still beautiful: why a number of companies get it wrong Drug Discov. Today 16 2011 476 484
2. Kay, J. (2010) Financial Times 24 March
3. A. Sampson Anatomy of Britain Today 1965 Publ. Hodder and Soughton
4. H.B. Fell, and R.W. Jubb The effect of synovial tissue on the breakdown of articular cartilage in organ culture Arthritis. Rheum. 20 1977 1359 1371
5. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 1975 256
6. M.J. Elliott Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110 (Pubitemid 24317629)